By Katherine Hamilton
Akari Therapeutics said it entered a securities purchase agreement for a private placement. The stock dropped 26% to $13.48 in after-hours trading Friday.
BlackSky Technology entered a sales agreement to offer and sell up to $250 million of Class A stock. Shares declined 3% to $46.49 after closing up 7%.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
May 22, 2026 18:35 ET (22:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.